NEJM January 12, 2021
With Jeremy Levin, DPhil, MB BChir, Evelyne Bischof, MD, MPH & Edward Prewitt, MPP

The pharma industry came together under extraordinary circumstances to develop a vaccine for Covid-19. Biotech and AI will play a major role in what’s to come next.

Summary

Jeremy Levin, CEO of Ovid Therapeutics and Chairman of the Biotechnology Innovation Organization, and Evelyne Bischof, Associate Professor at the Shanghai University School of Medicine and Health Sciences and a researcher at University Hospital in Basel, Switzerland, discuss the complexity of vaccine development for Covid-19, and what it can teach us for the future of vaccines, both as clinicians and patients.

Edward Prewitt, MPP, Editorial Director for NEJM Catalyst, interviews Jeremy Levin, CEO of Ovid Therapeutics...

 
Topics: Biotechnology, Govt Agencies, Healthcare System, Interview / Q&A, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Public Health, Trends
HHS Regulations With Enduring Impact On Pricing And Reimbursement Of Medical Services And Technologies
Incoming White House science and technology leader on AI, diversity, and society
12 Most Common Questions About Covid Mutations And Vaccines
Enabling new models of care: pursuing pharma’s partnership potential
The No. 1 lesson from the 2021 JP Morgan Healthcare Conference: Healthcare is 'too vital to fail'

Today's Sponsors

ZeOmega
holon
ClearDATA

Today's Sponsors

Philips
Healthcare NOW Radio

Today's Sponsor

Teladoc Health

2021-01-12T21:39:37-05:00